Bacitracin- and neomycin- and polymyxin B-containing product
RxNorm 477619
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 477619 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Bacitracin- and neomycin- and polymyxin B-containing product.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
MINPrescribable
Multiple Ingredients (MIN):
Bacitracin / neomycin / polymyxin B
(Atom ID: 12352387)
PTPrescribable
Designated preferred name (PT):
Bacitracin- and neomycin- and polymyxin B-containing product
(Atom ID: 10797445)
FNPrescribable
Full form of descriptor (FN):
Product containing bacitracin and neomycin and polymyxin B (medicinal product)
(Atom ID: 10810033)
Patient Education
Neomycin, Polymyxin, and Bacitracin Ophthalmic
Neomycin, polymyxin, and bacitracin ophthalmic combination is used to treat eye and eyelid infections. Neomycin, polymyxin, and bacitracin are in a class of medications called antibiotics. Neomycin, polymyxin, and bacitracin combination works by stopping the growth of bacteria infecting a surface of the eye.
[Learn More]
Neomycin, Polymyxin, and Bacitracin Topical
Neomycin, polymyxin, and bacitracin combination is used to prevent minor skin injuries such as cuts, scrapes, and burns from becoming infected. Neomycin, polymyxin, and bacitracin are in a class of medications called antibiotics. Neomycin, polymyxin, and bacitracin combination works by stopping the growth of bacteria.
[Learn More]
* Please review the disclaimer below.